Navigation Links
DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two million Americans are affected each year by DVT, with up to 600,000 hospitalized. Its primary complication, pulmonary embolism (PE), claims up to 300,000 lives annually -- more than breast cancer and AIDS combined. People who suffer from cardiovascular disease may be at increased risk for DVT, because these factors also heighten the likelihood of blood clots and pooling. Respiratory tract infection may increase risk of blood clots and is associated with inflammation, which may affect the proper functioning of arteries and veins.

The Coalition to Prevent Deep-Vein Thrombosis (DVT) recently sponsored an online survey of a nationally representative sample of consumers and physicians. The survey, which was conducted by Penn, Schoen & Berland Associates, assessed what Americans know about DVT.

The survey results point to an ongoing need for patients and physicians alike to know more about this leading cause of death and how they can reduce the risk of DVT. Following are the results specific to respiratory disease.

    Heart/respiratory patients recognize the significance of heart disease as

    a risk factor for DVT but incorrectly view pulmonary/respiratory disease

    as a much less significant threat.

       * 60% of heart/respiratory patients rate cardiac issues (e.g., heart

         disease, heart attack, arteriosclerosis or CHF) as very significant

         risk factors for DVT.

       * Only 35% see pulmonary/respiratory disease (e.g., asthma, COPD or

         emphysema) as a very significant risk factor.


    Even though they are at greater risk for DVT, heart/respiratory patients

    know only as much about it as the general population.

       * 52% of heart/respiratory patients have some knowledge about DVT -- on

         par with the general population (51%).

       * 40% of heart/respiratory patients have heard or read about DVT

         recently, the same percent
age as in the general population.


    Heart/respiratory patients who know something about DVT are no more likely

    than the general population to recognize key facts about the condition.

       * 17% of heart/respiratory patients correctly identify DVT as a blood

         clot, the same percentage as in the general population.

       * 17% recognize that DVT is a dangerous condition, one that can cause

         stroke or heart attack, or one that can be fatal.


    Despite their greater risk, heart/respiratory patients are no more likely

    than the general population to have discussed DVT with their physicians.

       * 10% of heart/respiratory patients report that their primary care

         physician has discussed DVT with them, compared with 12% of the

         general population.

       * 55% of heart/respiratory patients say that they are likely to ask

         their physicians for DVT information, vs. 50% of the general

         population.

The Coalition to Prevent Deep-Vein Thrombosis is funded by sanofi-aventis U.S. LLC

US.ENO.07.01.122

CONTACT: Shannon McIntyre, +1-212-614-4351

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Survey Reveals Significant Public Lack of Diabetes Awareness
2. DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
5. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
8. New Survey Finds Troubling Data on American Asthma Sufferers
9. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):